1. Home
  2. HTFL vs ATRC Comparison

HTFL vs ATRC Comparison

Compare HTFL & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartflow Inc.

HTFL

Heartflow Inc.

HOLD

Current Price

$48.49

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$56.64

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTFL
ATRC
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
2025
2005

Fundamental Metrics

Financial Performance
Metric
HTFL
ATRC
Price
$48.49
$56.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$38.20
$51.17
AVG Volume (30 Days)
2.1M
835.6K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
82.37
74.74
EPS
N/A
0.18
Revenue
$176,034,000.00
$201,630,000.00
Revenue This Year
$27.66
$15.27
Revenue Next Year
$23.55
$12.21
P/E Ratio
N/A
$303.00
Revenue Growth
39.92
15.40
52 Week Low
$20.13
$25.36
52 Week High
$51.78
$55.72

Technical Indicators

Market Signals
Indicator
HTFL
ATRC
Relative Strength Index (RSI) 66.88 78.90
Support Level $47.13 $26.95
Resistance Level $51.48 N/A
Average True Range (ATR) 2.40 1.95
MACD -0.71 0.12
Stochastic Oscillator 64.86 97.56

Price Performance

Historical Comparison
HTFL
ATRC

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: